Press release
Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG
DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report today! @ Influenza Pipeline Outlook [https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Influenza Pipeline Report
* August 2024:- Hoffmann-La Roche- A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza. The purpose of this study is to evaluate the pre-treatment and single-dose post treatment susceptibility of baloxavir marboxil in participants aged 1 to
* August 2024:- Janssen Vaccines & Prevention B.V.- A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy Adults. The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG here
News-ID: 3635365 • Views: …
More Releases from ABNewswire
How The Moss Way Is Redefining Quality with Hand-Harvested Irish Sea Moss
In an era where wellness claims often outpace scientific backing, one British brand is charting a different course. The Moss Way, a pioneering natural health company, is challenging the status quo of the superfood industry by delivering what many consider the purest, most potent Irish Sea Moss available in the UK market today.
London, United Kingdom - November 25, 2025 - In an era where wellness claims often outpace scientific backing,…
Verde Trader Unveils Enhanced Bulk Packaging Solutions with Focus on Gaylord Box …
Austin, TX - Verde Trader [https://verdetrader.com/], a national leader in the buy-sell-recycle industrial packaging marketplace, today announced an expanded offering and renewed focus on bulk corrugated containers-specifically the versatile "Gaylord box" (pallet-sized bulk bin). As more businesses face tighter sustainability requirements and supply-chain constraints, Verde Trader's enhanced inventory and support for Gaylord boxes aims to deliver savings, flexibility and green credentials in one package.
Why Gaylord Boxes?
Gaylord boxes (also known as…
HakkoAI Surpasses 10 Million Registered Users Worldwide Just Two Months After La …
Singapore - November 25th, 2025 - HakkoAI surpasses 10 million users within two months of its September release, marking rapid growth for Chinese startup LynkSoul's specialized gaming AI model. HakkoAI is based on LynkSoul VLM v1. It is one of the first AI models designed specifically for gaming scenarios, and it was named Product of the Day on Product Hunt.
Image: https://www.abnewswire.com/upload/2025/11/a4a0bd3acf5e0c23eb3b0185e429ebdb.jpg
Embodying the mission "Stay by Your Side, In Game and…
Meet Paulina Jayne: The Artist Inspiring a New Wave of Movement in CopperJoint's …
CopperJoint, the performance-inspired wellness brand known for its compression wear and movement-forward philosophy, proudly spotlights Nashville singer-songwriter Paulina Jayne, the artistic force behind the inspiration for its new Pink Sock Collection.
A Rising Nashville Artist with a Message That Moves People
Paulina Jayne is a Nashville-based singer-songwriter whose vibrant presence, powerful storytelling, and uplifting spirit have earned her a dedicated and expanding fanbase. With music rooted in confidence, resilience, and joy, Paulina's…
More Releases for Influenza
Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.…
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859
This latest report researches the industry structure, sales, revenue,…
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which…
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which…
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,…
